Retatrutide: Triple Agonist Mechanism, Structure, Pharmacokinetics and Current Research
An educational overview of retatrutide (LY3437943), an investigational triple GIP/GLP-1/glucagon receptor agonist being studied for obesity and type 2 diabetes, covering its structure, mechanism, pharmacokinetics, and clinical research.


